Welcome to InterK

InterK Peptide Therapeutics is a preclinical biotechnology company developing immune-boosting synthetic peptides with potential use as adjuvants in vaccination strategies, promoting DNA repair following UV irradiation, maintaining immune tolerance during cancer immunotherapy AND endometriosis.